Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract

Advanced Drug Delivery Reviews

Volumn 46, Issue 1-3, 2001, Pages 75-87

  Horter D ^a   Dressman, J B ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Complexation; Dissolution; GI physiology; Pka; Polymorphism; Solubilization; Wetting diffusivity

Indexed keywords

DRUG;

ANIMAL; CHEMISTRY; DIGESTIVE SYSTEM; HUMAN; METABOLISM; PHARMACOKINETICS; PHYSICAL CHEMISTRY; REVIEW; SOLUBILITY; SURFACE PROPERTY;

ANIMALS; CHEMISTRY, PHYSICAL; DIGESTIVE SYSTEM; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY; SURFACE PROPERTIES;

EID: 0035292910     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00130-7     Document Type: Article

References (59)

1. Katchen, B. and Symchowicz, S. (1967) Correlation of dissolution rate and griseofulvin absorption in man. J. Pharm. Sci. 56, 1108-1110.
2. Al-Saieq, S.S. and Riley, G.S. (1982) Polymorphism in sulphonylurea hypoglycaemic agents: II. chlorpropamide. Pharm. Acta Helv. 57, 8-11.
3. Haleblian, J. and McCrone, W. (1969) Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58, 911-929.
4. Dresse, A., Gérard, M.A., Lays, A., Tempero, K.F. and Verhaest, L. (1978) Human pharmacokinetics of two crystalline and galenic forms of diflunisal, a new analgesic. Pharm. Acta Helv. 53, 177-181.
5. Aguiar, A.J., Krc, J., Kinkel, A.W. and Samyn, J.C. (1967) Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56, 847-853.
6. Attwood, D. and Florence, A.T. (1983) Solubilization. In: Surfactant Systems. Chapman and Hall, London, p. 229.
7. Collett, J.H. and Koo, L. (1975) Interaction of substituted benzoic acids with polysorbate 20 micelles. J. Pharm. Sci. 64, 1253-1255.
8. Barry, B.W. and El Eini, D.I.D. (1976) Solubilization of hydrocortisone, dexamethasone, testosterone and progesterone by long-chain polyoxyethylene surfactants. J. Pharm. Pharmacol. 28, 210-218.
9. Attwood, D. and Florence, A.T. (1983) Pharmaceutical aspects of solubilization. In: Surfactant Systems. Chapman and Hall, London, pp. 298-299.
10. Tomida, H., Yotsuyanagi, T. and Ikeda, K. (1978) Solubilization of steroid hormones by polyoxyethylene lauryl ether. Chem. Pharm. Bull. 26, 2832-2837.
11. Bates, T.R., Gibaldi, M. and Kanig, J.L. (1966) Solubilizing properties of bile salt solutions I: Effect of temperature and bile salt concentration on solubilization of glutethimide, griseofulvin and hexestrol. J. Pharm. Sci. 55, 191-199.
12. Kassem, M.A., Mattha, A.G., El-Nimr, A.E.M. and Omar, S.M. (1982) Study on the influence of sodium taurocholate (STC) and sodium glycocholate (SGC) on the mass transfer of certain drugs. Digoxin. Int. J. Pharm. 12, 1-9.
13. 4 antagonist in micellar solutions. J. Pharm. Sci. 81, 483-485.
14. Luner, P.E., Babu, S.R. and Radebaugh, G.W. (1994) The effects of bile salts and lipids on the physicochemical behavior of gemfibrozil. Pharm. Res. 11, 1755-1760.
15. Shankland, W., (1970) The equilibrium and structure of lecithin-cholate mixed micelles. Chem. Phys. Lipids 4, 109-130.
16. Rosoff, M. and Serajuddin, A.T.M., (1980) Solubilization of diazepam in bile salts and in sodium cholate-lecithin-water phases. Int. J. Pharm. 6, 137-146.
17. Mithani, S.D., Bakatselou, V., Tenhoor, C.N. and Dressman, J.B. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res., in press.
18. Miyazaki, S., Yamahira, T., Morimoto, Y. and Nadai, T. (1981) Micellar interaction of indomethacin and phenylbutazone with bile salts. Int. J. Pharm. 8, 303-310.
19. Stella, V.J. and Pipkin, J.D. (1976) Phenylbutazone ionization kinetics. J. Pharm. Sci. 65, 1161-1165.
20. Russell, T.L., Berardi, R.R., Barnett, J.L., Dermentzoglou, L.C., Jarvenpaa, K.M., Schmaltz, S.P. and Dressman, J.B. (1993) Upper gastrointestinal pH in 79 healthy, elderly, North American men and women. Pharm. Res. 10, 187-196.
21. Evans, D.F., Pye, G., Bramley, R., Clark, A.G., Dyson, T.J. and Hardcastle, J.D. (1988) Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29, 1035-1041.
22. Dressman, J.B., Berardi, R.R., Dermentzoglou, L.C., Russell, T.L., Schmaltz, S.P., Barnett, J.L. and Jarvenpaa, K.M. (1991) Upper gastrointestinal pH in young, healthy men and women. Pharm. Res. 7, 756-761.
23. Ovesen, L., Bentsen, F., Tage-Jensen, U., Pedersen, N.T., Gram, B.R. and Rune, S.J. (1986) Intraluminal pH in the stomach, duodenum and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90, 958.
24. Borgstrom, B., Dahlquist, A., Lundh, G. et al. (1957) Studies of intestinal digestion and absorption in the human. Journal of Clinical Investigation 36, 1521-1536.
25. Malagelada, J.R., Longstreth, G.F., Summerskill, W.H.J. and Go, V.L.W. (1976) Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70, 203-210.
26. Slum, R.A., D'Andrea, D.T., Florentino, B.M., Wilton, J.H., Hilligoss, D.M., Gardner, M.J., Henry, E.B., Goldstein, H. and Schentag, J.J. (1991) Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann. Intern. Med. 114, 755-757.
27. Zimmermann, T., Yeates, R.A., Laufen, H., Pfaff, G. and Wildfeuer, A. (1994) Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur. J. Clin. Pharmacol. 46, 147-150.
28. Martindale, W. (1982), Dissociation Constants. In: The Extra Pharmacopeia. The Pharmaceutical Press, London, pp. XXIV-XXVII.
29. Lake-Bakaar, G., Tom, W., Lake-Bakaar, D., Gupta, N., Beidas, S., Elsakr, M. and Straus, E. (1988) Gastropathy and ketoconazole malabsorption in the Acquired Immuno-Deficiency Syndrome (AIDS). Ann. Intern. Med. 109, 471-473.
30. Brammer, K.W. and Tarbit, M.H. (1987) A review of the pharmacokinetics of fluconazole (UK-49 858) in laboratory animals and man. In: R.A. Fromtling (Ed.), Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. J.R. Prous Science Publishers, Barcelona, pp. 141-149.
31. Deppeler, H.P. (1981) Hydrchlorothiazide. In: K. Florey (Ed.), Analytical Profiles of Drug Substances, Volume 10. Academic Press, New York, pp. 405-437.
32. Ozturk, S.S., Palsson, B.O. and Dressman, J.B. (1988) Dissolution of ionizable drugs in buffered and unbuffered solutions. Pharm. Res. 5, 272-282.
33. Rasool, A.A., Hussain, A.A. and Dittert, L.W. (1991) Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds. J. Pharm. Sci. 80, 387-393.
34. Truelove, J., Bawarshi-Nassar, R., Chen, N.R. and Hussain, A. (1984) Solubility enhancement of some developmental anti-cancer nucleoside analogs by complexation with nicotinamide. Int. J. Pharm. 19, 17-25.
35. Tokumura, T., Nanba, M., Tsushima, Y., Tatsuishi, K., Masanori, K., Machida, Y and Nagai, T. (1986) Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with D,L-phenylalanine as a competing agent. J. Pharm. Sci. 75, 391-394.
36. Woodcock, B.G., Acerbi, D., Merz, P.G., Rietbrock, S. and Rietbrock, N. (1993) Supermolecular inclusion of piroxicam with β-cyclodextrin: pharmacokinetic properties in man. Eur. J. Rheumatol. Inflamm. 12, 12-28.
37. Miyayi, T., Inoue, Y, Acarturk, F., Imai, T., Otagiri, M. and Uekama K. (1992) Improvement of oral bioavailability of fenbufen by cyclodextrin complexations. Acta Pharm. Nord. 4, 17-22.
38. Dressman, J.B., Ridout, G. and Guy, R.H. (1990) Delivery system technology. In: C. Hansch, P.G. Sammes and J.B. Taylor (Eds.), Comprehensive Medicinal Chemistry, Volume 5. Biopharmaceutics. Pergamon Press, Oxford, p. 632.
39. Brewster, M.E., Anderson, W.R., Estes, K.S. and Bodor, N. (1991) Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins. J. Pharm. Sci. 80, 380-383.
40. Tinwalla, A.Y., Hoesterey, B.L., Xiang, T., Lim, K. and Anderson B.D. (1993) Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-β-cyclodextrin. Pharm. Res. 10, 1136-1143.
41. Järvinen, T., Järvinen, K., Schwarting, N. and Stella, V.J. (1995) β-Cyclodextrin derivatives, SBE-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs. J. Pharm. Sci. 84, 295-299.
42. Okada, Y., Tachibana, M. and Koizumi, K. (1990) Solubilization of lipid-soluble vitamins by complexation with glucosyl-β-cyclodextrin. Chem. Pharm. Bull. 38, 2047-2049.
43. Acartürk, F., Imai, T., Saito, H., Ishikawa, M. and Otagiri, M. (1993) Comparative study on inclusion complexation of maltosyl-β-cyclodextrin, heptakis(2,6-di-O-methyl)-β-cyclodextrin and β-cyclodextrin with fucosterol in aqueous and solid state. J. Pharm. Pharmacol. 45, 1028-1032.
44. Okada, Y., Kubota, Y., Koizumi, K., Hizukuri, S., Ohfuji, T. and Ogata, K. (1988) Some properties and the inclusion behavior of branched cyclodextrins. Chem. Pharm. Bull. 36, 2176-2185.
45. Macheras, P.E., Koupparis, M.A. and Antimisiaris, S.G. (1990) Drug binding and solubility in milk. Pharm. Res. 7, 537-541.
46. Macheras, RE. and Reppas, C.I. (1986), Studies on drug-milk freeze dried formulations I: bioavailability of sulfamethizole and dicumarol formulations. J. Pharm. Sci. 75, 692-696.
47. Welling, P.G. (1977) Influence of food and diet on gastrointestinal drug absorption: a review. J. Pharmacokinet. Biopharm. 5, 291-334.
48. Solvang, S. and Finholt, P. (1970) Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice. J. Pharm. Sci. 59, 49-52.
49. Einholt, P. and Solvang, S. (1968) Dissolution kinetics of drugs in human gastric juice - the role of surface tension. J. Pharm. Sci. 57, 1322-1326.
50. Bakatselou, V., Oppenheim, R.C. and Dressman, J.B. (1991) Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 8, 1461-1469.
51. Miyazaki, S., Inoue, H., Yamahira, T. and Nadai, T. (1979) Interaction of drugs with bile components I: Effect of bile salts on the dissolution behavior of indomethacin and phenylbutazone. Chem. Pharm. Bull. 27, 2468-2472.
52. Naylor, L.J., Bakatselou, V. and Dressman, J.B. (1993) Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm. Res. 10, 865-870.
53. Naylor, L.J., Bakatselou, V., Rodriguez-Hornedo, N., Weiner, N.D. and Dressman, J.B. (1995) Dissolution of steroids in bile salt solutions is modified by the presence of lecithin. Eur. J. Pharm. Biopharm. 41, 346-353.
54. Braun, R.J. and Parrott, E.L. (1972) Influence of viscosity and solubilization on dissolution rate. J. Pharm. Sci. 61, 175-178.
55. Wurster, D.E. and Polli, G.P. (1964) Investigation of drug release from solids V: Simultaneous influence of adsorption and viscosity on the dissolution rate. J. Pharm. Sci. 53, 311-314.
56. Reppas, C., Meyer, J.H., Sirois, P.J. and Dressman, J.B. (1991) Effect of hydroxypropylmethylcellulose on gastrointestinal transit and luminal viscosity in dogs. Gastroenterology 100, 1217-1223.
57. Eeckhout, C., De-Wever, I., Vantrappen, G. and Janssens, J. (1980) Local disorganization of interdigestive migrating complex by perfusion of a Thiry-Vella loop. Am. J. Physiol. 238, 509-513.
58. Banakar, U.V., Lathia, C.D. and Wood, J.H. (1991) Interpretation of dissolution rate data and techniques of in vivo dissolution. In: U.V. Banakar (Ed.), Pharmaceutical Dissolution Testing. Marcel Dekker, Inc., New York, p. 212.
59. AGA Undergraduate Teaching Project, Gastroenterology-Liver Disease. Unit 10B. Alimentary Tract Motility. Milner-Fenwick, Inc. MD, USA, Fig. 58.